We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Clinical and Technology Focus of New Medtech Startups
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Clinical and Technology Focus of New Medtech Startups
Medical DevicesMedical InnovationsTechnology

Clinical and Technology Focus of New Medtech Startups

PatrickDriscoll
PatrickDriscoll
Share
3 Min Read
Screen Shot 2014-03-22 at 1.08.50 PM
SHARE

Since January 2011, a total of 245 new medtech companies have been founded and added to the Medtech Startups Database from MedMarket Diligence. These are companies that are either device-based or based on other technologies that are directly competitive with, or complementary to, medical devices, inclusive of medical device implants, med/surg instruments or equipment, drug/device or biotech/device hybrids, bioresorable implants/devices and other similar technologies.

Since January 2011, a total of 245 new medtech companies have been founded and added to the Medtech Startups Database from MedMarket Diligence. These are companies that are either device-based or based on other technologies that are directly competitive with, or complementary to, medical devices, inclusive of medical device implants, med/surg instruments or equipment, drug/device or biotech/device hybrids, bioresorable implants/devices and other similar technologies. The companies excluded from this are those that are developign pure pharmaceutical products with no direct competitive/complementary role with medical devices or hybrids of info technology (e.g., smart-phone) piggybacked on existing medical devices.

The companies represented here cover a surprising range of innovations and clinical applications. They have been identified based on recently issued patents, patent applications, corporate filings and a litany of press releases, social media sources, and other data sources. As we identify the companies during this process, we categorize them into a number of clinical/technology categories, with multiple categories possible (e.g., minimally invasive plus cardio therapeutics, or diagnostic plus oncology, and others). Below is illustrated, in descending order, the clinical/technology categories of the companies founded since January 2011:

Screen Shot 2014-03-22 at 1.08.50 PM

More Read

Entering a New Era for Clinical Computing and Patient Engagement
Advanced Data Analytics and Machine Learning in Healthcare Cybersecurity
HIMSS14: Bullish on Growth in the International Healthcare IT Market
Healthcare Industry Enters the Mobile World
Good Payment Processors Make Dental Care More Affordable

Source: Medtech Startups Database; MedMarket Diligence, LLC

Clearly, the great majority of medical technology startup companies is focused on surgical and/or cardio therapeutics and/or minimally invasive and/or orthomusculoskeletal applications, areas that have historically and persistently represented the dominant thrust of medtech innovation.

Another way to view these companies is a “word cloud” compiled from each company’s product/technology descriptions, with the most frequently occurring words in the descriptions being represented in larger type face in the graphic:
Screen Shot 2014-03-22 at 12.53.46 PM

Source: Medtech Startups Database; MedMarket Diligence, LLC

Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Workers Comp Claim Denied – Now What?  -- AI-generated illustration
Workers Comp Claim Denied – Now What? 
Policy & Law
October 9, 2026
The Case for Proactive Nutrient Support and Where IV Therapy Fits In -- AI-generated illustration
The Case for Proactive Nutrient Support and Where IV Therapy Fits In
Health Therapies
October 5, 2026
Biofeedback Technology in Addiction Treatment: What the Evidence Shows So Far -- AI-generated illustration
Biofeedback Technology in Addiction Treatment: What the Evidence Shows So Far
Addiction Addiction Recovery
September 28, 2026
Charity Care Is Written Into Hospital Policy. It Rarely Makes It Onto the Bill. -- AI-generated illustration
Charity Care Is Written Into Hospital Policy. It Rarely Makes It Onto the Bill.
Business Hospital Administration
September 25, 2026

You Might also Like

Choosing a Beverly Hills Hyperbaric Center Means Checking Access and Transparency  -- AI-generated illustration
Medical InnovationsTechnology

Choosing a Beverly Hills Hyperbaric Center Means Checking Access and Transparency 

August 10, 2026
Ben Loop, Vice President of Care Coordination and Analytics for Siemens
BusinessHospital AdministrationTechnology

HIMSS14: Why We Need Healthcare Intelligence (As Well As Intelligent Healthcare)

February 27, 2014

New Telestroke Initiative Discussion Group Added

May 24, 2011
Health careTechnology

Data Mining And Healthcare: How Treatment Can Be Improved By Data Collection

February 20, 2020
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?